Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

SmithKline Beecham enters copromotion agreement with Bristol-Myers Squibb for Avandia

April 26, 1999

HMR seeks approval for long-acting insulin in U.S. and Europe

April 26, 1999

SS Pharm. presents new AGE inhibitors for use in diabetic complications

April 26, 1999

Pharmacokinetics of Prandin shown to be similar in young adults and elderly

April 26, 1999

HP-228 reduces obesity and insulin resistance in animal models

April 23, 1999

Avandia approved in Mexico, approval recommended in U.S.

April 23, 1999

Novel cytotoxic agent from Nippon Steel with potential in inflammation and osteoporosis

April 22, 1999

Abarelix depot is safe and effective in patients with endometriosis

April 22, 1999

Novavax estrogen cream completes phase II trial

April 22, 1999

Hemosol's oxygen carrier cleared for phase III trials in Canada

April 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...